5 Cardiovascular and renal outcomes with GLP-1RA in T1D In patients with T2D, large RCT studies have shown that GLP-1RA treatment reduces the risk of cardiovascular and renal outcomes (70)
Several nuclear-encoded assembly factors, including SURF1, SCO1, SCO2, COX10, COX15, and LRPPRC, are involved in the assembly of complex IV (93)
The combination of glucagon receptor activation with appropriate resistance training and protein intake creates optimal conditions for losing fat while maintaining muscle
Below, well break down how cagrilintide works, what clinical trials show so far, how it compares with existing options like Wegovy and Zepbound, and what the road ahead may look like for approval and availability
As pigmentation is corrected, protecting new skin from UV-induced darkening is absolutely critical